University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 13 of 35
Incorporating PRO Data Into RA Clinical Encounters Using Health IT
NCT06655077
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer
NCT04005144
Backpack Weight Impacts
NCT04249986
Identification of Microbial DNA in Maternal Plasma After PPROM
NCT04318470
Expanded NIPT for Pregnancy Complications
NCT04311749
AI Activity Study in Patients With Elevated Blood Pressure
NCT03969056
Diabetes and Depression Text Messaging Intervention
NCT03490253
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer
NCT03554044
Optimizing Acute Post-Operative Dental Pain Management Using New Health Information Technology
NCT03881891
Liberation From Acute Dialysis
NCT04218370
The Effect of Chronic Pain on Delay Discounting in Methadone Patients
NCT04473950
COVID-19 and Venous Thromboembolism Risk
NCT04569344
Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer
NCT03503344
Evaluating the Comparative Pharmacokinetics of Nicotine After Administration Via JUUL or Tobacco Cigarettes
NCT04053868
A Trial of High Power-Short Duration Versus Standard Power-Long Duration Radiofrequency Ablation for Treatment of Atrial Fibrillation
NCT04148664
Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men
NCT03980223
Empower Opioid Misuse & Chronic Pain
NCT04184362
Engaging Mothers & Babies; Reimagining Antenatal Care for Everyone (EMBRACE) Study
NCT04154423
A Study of Adolescents Undergoing a Mindfulness Training During COVID-19
NCT04548544
At-home Transcranial Alternating Current Stimulation During Multitasking
NCT04231825
Autonomic Mechanisms of Sleep-dependent Memory Consolidation
NCT04021797
Wayfinding Intervention in High-Fidelity Long-Term Memory
NCT04253587
Development of a Mobile App for an Executive Functioning Intervention for Adolescents
NCT04018794
Melatonin for Sleep in MS
NCT04035889
Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis
NCT04002141
Behavioral Approaches to Reducing Diabetes Distress and Improving Glycemic Control
NCT04016558
Investigating the Effect of Single-session Sauna Use on Body Temperature
NCT04249700
Azithromycin for Meibomian Gland Disease
NCT03953118
Mindfulness-based Cognitive Therapy (MBCT) for People With Parkinson's Disease
NCT03904654
CONNECT: Smoking Cessation and Lung Cancer Screening
NCT04149249
Empower Korean Families to End Tobacco Use & Smoking Exposure
NCT04079569
The PCORnet Blood Pressure Home Monitoring Study
NCT03796689
PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness
NCT03950427
Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli
NCT03946072
mHealth App for Engagement in Care Among Youth Living With HIV
NCT03587857
Family Telehealth Project for Foster Care Youth
NCT04488523
Improving BP Control in Diverse Populations Using BP MAP
NCT03818659
Double-Blind Randomized Controlled Trial for the Evaluation of a Novel Adaptive Attention Training in Healthy Adolescents
NCT03213613
Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)
NCT04014387
Nobio Clinical Study - Demineralization Prevention With a New Antibacterial Restorative Composite
NCT04059250
Microbiologic Alterations of the Conjunctiva of Hot Tub-soaking Ophthalmologists
NCT03987178
Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study
NCT02531295
177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
NCT03805594
Coffee and Real-time Atrial and Ventricular Ectopy
NCT03671759
Coping After Pediatric Scoliosis Surgery
NCT04063670
Pupillary Unrest in Ambient Light, and Relationship to Opioid-Induced Respiratory Depression
NCT04301895
Computerized Cognitive Training in MS
NCT03737825
Drug-Drug Interaction Between Rifampin and Fluvastatin
NCT04029584
Weight Patterns in the Month After Birth
NCT04025827
Social Experiences and Sleep Study
NCT03937973
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.